# ctDNA Screening in Advanced HER2 Positive Gastric Cancer

> **NCT04520295** · — · UNKNOWN · sponsor: **Ruijin Hospital** · enrollment: 100 (estimated)

## Conditions studied

- HER2-positive Gastric Cancer

## Interventions

- **GENETIC:** ctDNA screening

## Key facts

- **NCT ID:** NCT04520295
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-19
- **Primary completion:** 2023-05-31
- **Final completion:** 2025-05-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04520295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04520295, "ctDNA Screening in Advanced HER2 Positive Gastric Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04520295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*